Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jan-24 6:26 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 02-Jan-24 | Option Exercise | 20,000 | $12.98 | $259,600.00 | 47% 42.78K to 62.78K | |
| 04-Jan-24 6:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Jan-24 | Planned Option Sale | 11,044 | $131.47 | $1,451,930.00 | (18%) 62.78K to 51.74K | |
| 03-May-23 5:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-May-23 | Option Exercise | 7,625 | $12.71 | $96,913.80 | 19% 39.46K to 47.09K | |
| 03-May-23 5:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-May-23 | Planned Option Sale | 4,300 | $101.43 | $436,135.00 | (9%) 47.09K to 42.78K | |
| 21-Apr-23 6:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Apr-23 | Option Exercise | 10,765 | $12.71 | $136,823.00 | 13% 80.22K to 90.99K | |
| 21-Apr-23 6:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Apr-23 | Planned Option Sale | 6,034 | $105.04 | $633,787.00 | (7%) 90.99K to 84.95K | |
| 21-Apr-23 6:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-Apr-23 | Option Exercise | 1,610 | $12.71 | $20,463.10 | 2% 79.52K to 81.13K | |
| 21-Apr-23 6:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-Apr-23 | Planned Option Sale | 903 | $105.00 | $94,818.60 | (1%) 81.13K to 80.22K | |
| 13-Jun-22 4:43 PM View: | Fate Therapeutics Inc (FATE) | 09-Jun-22 | Grant | 8,650 | -- | -- | 1% 608.77K to 617.42K | |
| 05-Apr-22 6:20 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Apr-22 | Option Exercise | 20,000 | $6.66 | $133,200.00 | 81% 24.75K to 44.75K | |
| 05-Apr-22 6:20 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Apr-22 | Planned Option Sale | 10,728 | $94.93 | $1,018,370.00 | (24%) 44.75K to 34.02K | |
| 04-Jun-21 5:30 PM View: | Fate Therapeutics Inc (FATE) | 02-Jun-21 | Grant | 2,681 | -- | -- | < 1% 606.09K to 608.77K | |
| 31-Mar-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 30-Mar-20 | Option Exercise | 28,461 | $1.37 | $38,991.60 | 100% 0 to 28.46K | |
| 04-Feb-20 5:05 PM View: | Regulus Therapeutics Inc. (RGLS) | 03-Feb-20 | Conversion | 225,940 | -- | -- | 137% 164.64K to 390.58K | |
| 08-May-19 5:14 PM View: | Regulus Therapeutics Inc. (RGLS) | 07-May-19 | Private Purchase | 92,889 | $1.08 | $100,320.00 | 151% 61.33K to 154.22K | |
| 13-Nov-18 5:33 PM View: | Regulus Therapeutics Inc. (RGLS) | 12-Nov-18 | Grant | 23,258 | -- | -- | 41% 56.41K to 79.67K | |
| 26-Jan-18 4:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Jan-18 | Option Exercise | 20,000 | $7.05 | $141,000.00 | 140% 14.25K to 34.25K | |
| 26-Jan-18 4:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Jan-18 | Market Option Sale (Planned) | 9,500 | $90.00 | $855,000.00 | (28%) 34.25K to 24.75K | (28%) |
| 06-Dec-17 7:38 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-17 | Grant | 69,662 | $0.89 | $61,999.20 | 11% 624.73K to 694.39K | (84%) |
| 25-Jul-17 6:09 PM View: | Regulus Therapeutics Inc. (RGLS) | 25-Jul-17 | Private Purchase Duplicate | 274,725 | $0.91 | $250,000.00 | 79% 349.9K to 624.63K | |
| 07-Mar-17 4:59 PM View: | Regulus Therapeutics Inc. (RGLS) | 07-Mar-17 | Market Purchase | 250,000 | $1.15 | $287,500.00 | 250% 100.0K to 350.0K | (87%) |
| 02-Feb-17 7:29 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Feb-17 | Option Exercise | 25,000 | $2.17 | $54,250.00 | 100% 0 to 25.0K | |
| 02-Feb-17 7:29 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Feb-17 | Market Option Sale (Planned) | 10,750 | $42.28 | $454,510.00 | (43%) 25.0K to 14.25K | (173%) |
| 05-Jan-17 4:24 PM View: | Cerulean Pharma Inc. (DARE) | 03-Jan-17 | Grant | 24,350 | $0.77 | $18,749.50 | 31% 78.69K to 103.04K | (82%) |
| 28-Nov-16 3:44 PM View: | Fate Therapeutics Inc (FATE) | 23-Nov-16 | Private Purchase | 375,939 | $2.66 | $999,998.00 | 186% 201.69K to 577.63K | |
| 20-Oct-16 7:01 PM View: | Cerulean Pharma Inc. (DARE) | 03-Oct-16 | Grant | 18,382 | $1.02 | $18,749.60 | 30% 60.31K to 78.69K | (85%) |
| 04-Jan-16 6:13 PM View: | Illumina Inc. (ILMN) | 31-Dec-15 | Grant | 182 | $164.14 | $29,873.10 | < 1% 94.99K to 95.17K | |
| 02-Oct-15 6:19 PM View: | Illumina Inc. (ILMN) | 30-Sep-15 | Grant | 145 | $205.90 | $29,856.00 | < 1% 94.85K to 94.99K | |
| 27-Aug-15 6:39 PM View: | Receptos, Inc. (RCPT) | 27-Aug-15 | Disposition | 7,400 | -- | -- | (100%) 7.4K to 0 | |
| 27-Aug-15 6:39 PM View: | Receptos, Inc. (RCPT) | 25-Aug-15 | Disposition (change in control) | 332,234 | -- | -- | (98%) 339.63K to 7.4K | |
| 21-Jul-15 8:47 PM View: | Regulus Therapeutics Inc. (RGLS) | 21-Jul-15 | Market Purchase | 61,235 | $10.19 | $624,199.00 | 158% 38.77K to 100.0K | (99%) |
| 21-Jul-15 8:47 PM View: | Regulus Therapeutics Inc. (RGLS) | 20-Jul-15 | Market Purchase | 38,765 | $10.13 | $392,779.00 | 100% 0 to 38.77K | (99%) |
| 01-Jul-15 6:31 PM View: | Illumina Inc. (ILMN) | 30-Jun-15 | Grant | 149 | $201.07 | $29,958.80 | < 1% 94.7K to 94.85K | |
| 01-Jun-15 8:41 PM View: | Receptos, Inc. (RCPT) | 28-May-15 | Grant | 7,400 | -- | -- | 2% 332.23K to 339.63K | |
| 28-May-15 7:48 PM View: | Illumina Inc. (ILMN) | 27-May-15 | Grant | 1,910 | -- | -- | 2% 92.79K to 94.7K | |
| 02-Apr-15 7:28 PM View: | Illumina Inc. (ILMN) | 31-Mar-15 | Grant | 155 | $193.28 | $29,958.30 | < 1% 92.63K to 92.79K | 55% |
| 22-Jan-15 3:19 PM View: | Illumina Inc. (ILMN) | 20-Jan-15 | Option Exercise | 16,000 | $6.22 | $99,600.00 | 17% 92.63K to 108.63K | |
| 22-Jan-15 3:19 PM View: | Illumina Inc. (ILMN) | 20-Jan-15 | Market Option Sale (Planned) | 16,000 | $188.99 | $3,023,890.00 | (15%) 108.63K to 92.63K | (59%) |
| 02-Jan-15 4:06 PM View: | Illumina Inc. (ILMN) | 31-Dec-14 | Grant | 160 | $179.56 | $28,729.30 | < 1% 92.47K to 92.63K | 67% |
| 30-Sep-14 7:59 PM View: | Illumina Inc. (ILMN) | 30-Sep-14 | Grant | 167 | $172.12 | $28,744.70 | < 1% 92.31K to 92.47K | 74% |
| 30-Sep-14 7:59 PM View: | Illumina Inc. (ILMN) | 29-Sep-14 | Market Sale (Planned) | 248 | $163.73 | $40,605.00 | (< 1%) 92.55K to 92.31K | (83%) |
| 01-Jul-14 7:22 PM View: | Illumina Inc. (ILMN) | 30-Jun-14 | Grant | 187 | -- | -- | < 1% 92.7K to 92.89K | |
| 01-Jul-14 7:22 PM View: | Illumina Inc. (ILMN) | 30-Jun-14 | Market Sale (Planned) | 334 | $174.34 | $58,229.60 | (< 1%) 92.89K to 92.55K | (72%) |
| 29-May-14 6:48 PM View: | Illumina Inc. (ILMN) | 28-May-14 | Grant | 2,542 | -- | -- | 3% 90.16K to 92.7K | |
| 22-Apr-14 7:12 PM View: | Illumina Inc. (ILMN) | 21-Apr-14 | Market Sale (Planned) | 879 | $135.82 | $119,386.00 | (< 1%) 91.04K to 90.16K | (121%) |
| 17-Apr-14 3:09 PM View: | Cerulean Pharma Inc. (DARE) | 15-Apr-14 | Conversion | 41,438 | -- | -- | 100% 41.44K to 82.88K | |
| 17-Apr-14 3:09 PM View: | Cerulean Pharma Inc. (DARE) | 15-Apr-14 | Market Purchase | 18,869 | $7.00 | $132,083.00 | 23% 82.88K to 101.75K | (98%) |
| 01-Apr-14 8:49 PM View: | Illumina Inc. (ILMN) | 31-Mar-14 | Grant | 190 | -- | -- | < 1% 91.14K to 91.33K | |
| 01-Apr-14 8:49 PM View: | Illumina Inc. (ILMN) | 31-Mar-14 | Market Sale (Planned) | 296 | $143.50 | $42,476.00 | (< 1%) 91.33K to 91.04K | (109%) |
| 05-Feb-14 8:43 PM View: | Illumina Inc. (ILMN) | 03-Feb-14 | Market Sale (Planned) | 8,551 | $151.93 | $1,299,150.00 | (9%) 99.69K to 91.14K | (97%) |